Navigation Links
ARVO Foundation and Merck to provide prestigious global ophthalmic research award
Date:11/3/2008

Rockville, MD -- The ARVO Foundation for Eye Research (AFER) and Merck & Co., Inc. are pleased to announce a series of awards that honor young scientists throughout the world for their innovative contributions to ophthalmology research. Each award cycle is worth a total of $70,000 in grants.

The ARVO-AFER/Merck Innovative Ophthalmology Research Award (IORA), formerly Merck's Chibret Award, created in honor of French ophthalmologist Dr. Paul Chibret, is designed to encourage researchers to undertake investigative work in critical areas of ophthalmology. Since its initiation in 1982, more than 50 scientists age 45 or younger have received the award.

Merck, a leader in ophthalmology for over 50 years, will sponsor the ARVO-AFER/Merck Innovative Ophthalmology Research Award through a donation to AFER. The award will be presented biennially beginning in 2009 (for submissions received in 2008). In addition to monetary prizes, the awards cover recipients' travel expenses and registration fees for the ARVO Annual Meeting, which takes place in Fort Lauderdale, FL, each April/May.

"Merck is proud to support the ARVO Foundation for Eye Research by continuing to sponsor this global award that recognizes promising scientists and their pioneering work in the field of ophthalmology," said Anastasia Daifotis, MD, Vice President, Global Medical Affairs, Merck & Co., Inc. "We hope that AFER's global efforts to encourage innovation and promote support for eye and vision research will continue to inspire even more young scientists."

"AFER is looking forward to opening more doors for young researchers through the Innovative Ophthalmology Research Award," added Gary Abrams, MD, Chairman of AFER's Board of Governors. "We welcome Merck's continuing support and commitment to rigorous, inventive ophthalmic research."

2009 ARVO-AFER/Merck IORA:

The application period for the 2009 award ended in June 2008. AFER, with assistance from ARVO, will conduct the review and selection process of eligible submissions. AFER will announce recipients of the 2009 awards in conjunction with the ARVO 2009 Annual Meeting (May 3-7). There will be first and second place award grants for each of two categories (glaucoma and back-of-the-eye diseases). The four grants total $70,000.

2010 and beyond:

Beginning in 2010, investigators at the MD, PhD or equivalent doctoral level degree from any part of the world will be invited to apply for the 2011 awards. ARVO will select two research topics and award six grants totaling $70,000.


'/>"/>

Contact: Joanne Olson
jolson@arvo.org
240-221-2923
Association for Research in Vision and Ophthalmology
Source:Eurekalert

Related medicine news :

1. National Patient Safety Foundation Partners with Vocera Communications
2. R. P. Simmons Family Foundation Pledges $2 Million for New Childrens Hospital of Pittsburgh of UPMC Campus
3. Patient Advocate Foundation Launches Program to Help Uninsured Virginians with Chronic, Debilitating and Life-Threatening Illness Access Quality Healthcare
4. AIDS Healthcare Foundation Applauds City Commissioners Support of Diversity, Urges Call for Mayors Resignation
5. National Osteoporosis Foundation Teams Up With Ladies Home Journal Magazine to Launch a 10-city Mall Walk Tour
6. Judge Rules That Florida Disease Management Program Serving 8,000 HIV/AIDS Patients Should Be Re-bid, Says AIDS Healthcare Foundation
7. The Tug McGraw Foundation Announces 2007 Fundraising Gala
8. The Arthur M. Blank Family Foundation Pushes for Pre-K Expansion in Georgia
9. Cipla, Tell the Truth; AIDS Healthcare Foundation Launches New Ad Campaign
10. Survey From The Partnership and MetLife Foundation Reveals Important Role Todays Grandparents Play in Teens Lives
11. Exceptional Childrens Foundation Merger with Kayne Eras Center Creates One of States Most Comprehensive Nonprofits Serving the Disabled
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/19/2017)... , ... January 19, 2017 , ... ... a medical capacity this year. Drs. Alexander Paziotopoulos, Andrew Petersen and Trish Henrie-Barrus ... condensed version of the clinic’s leading recovery program. , “We know it’s ...
(Date:1/19/2017)... ... January 19, 2017 , ... Bio-Optronics Inc. is ... modern CTMS workflow designed to seamlessly integrate and streamline the way researchers prepare ... single page, maximizing usability and improving efficiency significantly for users – a first ...
(Date:1/19/2017)... ... January 19, 2017 , ... ... panel system. , The Tranquility privacy panel system was designed to deliver ... Tranquility panels help reduce noise and provide the visual privacy required to maintain ...
(Date:1/19/2017)... ... 19, 2017 , ... Rountree Brady Insurance Agency, a Savannah ... eastern Georgia, is embarking on a charity effort to raise awareness and gather ... every year than anything else, yet risk factors associated with heart disease are ...
(Date:1/19/2017)... ... 2017 , ... Attorney Robert “RC” Pate , founder of The Law ... Triumph Over Kid Cancer foundation. Each year, 175,000 children are diagnosed with pediatric cancers. ... the effect of the critical funding gap for research into pediatric cancer research. From ...
Breaking Medicine News(10 mins):
(Date:1/19/2017)... January 18, 2017 , , Marks E-QURE ... distribution agreement, following similar agreements in Israel ... Wound care is $2 5 billion ... E-QURE Corp. (OTCQB: EQUR), a leader in medical devices for the treatment of ... Médica Equipos Médicos S.A.S. (TeckMedica) in Colombia for the ...
(Date:1/19/2017)... 18, 2017   Synthetic Biologics, Inc. ... therapeutics designed to preserve the microbiome to protect ... plans to initiate a Phase 2b/3 adaptive pivotal ... lovastatin lactone designed to reduce methane production by ... gut to treat the underlying cause of irritable ...
(Date:1/18/2017)... PAUL, Minn. , Jan. 18, 2017 /PRNewswire-USNewswire/ ... developer of medical devices using neuroblocking technology to ... today announced the pricing of an underwritten public ... million, prior to deducting underwriting discounts and commissions ... The offering is comprised of Class A Units, ...
Breaking Medicine Technology: